Found: 39
Select item for more details and to access through your institution.
Current Allergic Rhinitis Experiences Survey (CARES): Consumers' awareness, attitudes and practices.
- Published in:
- Allergy & Asthma Proceedings, 2014, v. 35, n. 4, p. 307, doi. 10.2500/aap.2014.35.3766
- By:
- Publication type:
- Article
Current Allergic Rhinitis Experiences Survey (CARES): Health-care practitioners' awareness, attitudes and practices.
- Published in:
- Allergy & Asthma Proceedings, 2014, v. 35, n. 4, p. 316, doi. 10.2500/aap.2014.35.3771
- By:
- Publication type:
- Article
Long-Term Dupilumab Efficacy on Severe Exacerbations and Lung Function in Patients with Type 2 Asthma.
- Published in:
- Annals of the American Thoracic Society, 2024, v. 21, n. 4, p. 675, doi. 10.1513/AnnalsATS.202306-544RL
- By:
- Publication type:
- Article
Prevalence of type 2 inflammatory signatures and efficacy of dupilumab in patients with chronic rhinosinusitis with nasal polyps from two phase 3 clinical trials: SINUS‐24 and SINUS‐52.
- Published in:
- International Forum of Allergy & Rhinology, 2024, v. 14, n. 3, p. 668, doi. 10.1002/alr.23249
- By:
- Publication type:
- Article
Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps: Association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS‐24 and SINUS‐52 trials
- Published in:
- International Forum of Allergy & Rhinology, 2022, v. 12, n. 9, p. 1191, doi. 10.1002/alr.22964
- By:
- Publication type:
- Article
Rapid and sustained effects of dupilumab in severe chronic rhinosinusitis with nasal polyps.
- Published in:
- International Forum of Allergy & Rhinology, 2022, v. 12, n. 7, p. 958, doi. 10.1002/alr.22944
- By:
- Publication type:
- Article
Biomarkers Associated with Lung Function Decline and Dupilumab Response in Patients with Asthma.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 209, n. 8, p. 1031, doi. 10.1164/rccm.202310-1751LE
- By:
- Publication type:
- Article
Baseline Systemic Oral Corticosteroid Use in Patients with Asthma Initiating Dupilumab Treatment in the Real World: From the RAPID Global Registry.
- Published in:
- Journal of Asthma & Allergy, 2024, v. 17, p. 551, doi. 10.2147/JAA.S451689
- By:
- Publication type:
- Article
Impact of Exacerbation History on Dupilumab Efficacy in Children with Uncontrolled Moderate-to-Severe Asthma: LIBERTY ASTHMA VOYAGE Study.
- Published in:
- Journal of Asthma & Allergy, 2024, v. 17, p. 143, doi. 10.2147/JAA.S416292
- By:
- Publication type:
- Article
Impact of Lung Function on Asthma Exacerbation Rates in Children Treated with Dupilumab: The VOYAGE Study.
- Published in:
- Journal of Asthma & Allergy, 2024, v. 17, p. 81, doi. 10.2147/JAA.S425101
- By:
- Publication type:
- Article
Dupilumab Reduces Asthma Disease Burden and Recurrent SCS Use in Patients with CRSwNP and Coexisting Asthma.
- Published in:
- Journal of Asthma & Allergy, 2024, v. 17, p. 1, doi. 10.2147/JAA.S420140
- By:
- Publication type:
- Article
Health-Related Quality of Life Impairment Among Patients with Severe Chronic Rhinosinusitis with Nasal Polyps in the SINUS-24 Trial.
- Published in:
- Journal of Asthma & Allergy, 2023, v. 16, p. 323, doi. 10.2147/JAA.S372598
- By:
- Publication type:
- Article
Dupilumab Improves Outcomes in Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma Irrespective of Baseline Asthma Characteristics.
- Published in:
- Journal of Asthma & Allergy, 2023, v. 16, p. 411, doi. 10.2147/JAA.S391896
- By:
- Publication type:
- Article
Dupilumab Efficacy in Patients with Uncontrolled Moderate-to-Severe Type 2 Asthma Regardless of Perennial Aeroallergen Sensitization.
- Published in:
- Journal of Asthma & Allergy, 2023, v. 16, p. 249, doi. 10.2147/JAA.S385645
- By:
- Publication type:
- Article
Improvement in Health-Related Quality of Life with Dupilumab in Patients with Moderate-to-Severe Asthma with Comorbid Chronic Rhinosinusitis with/without Nasal Polyps: An Analysis of the QUEST Study.
- Published in:
- Journal of Asthma & Allergy, 2022, v. 15, p. 767, doi. 10.2147/JAA.S363527
- By:
- Publication type:
- Article
Rapid and Continuing Improvements in Nasal Symptoms with Dupilumab in Patients with Severe CRSwNP.
- Published in:
- Journal of Asthma & Allergy, 2022, v. 15, p. 557, doi. 10.2147/JAA.S355391
- By:
- Publication type:
- Article
Improvement in Lung Function with Dupilumab Does Not Predict Its Effects on Reducing Asthma Exacerbation.
- Published in:
- Journal of Asthma & Allergy, 2022, v. 15, p. 851, doi. 10.2147/JAA.S354013
- By:
- Publication type:
- Article
Real-world effectiveness of dupilumab versus benralizumab and mepolizumab.
- Published in:
- Allergy & Asthma Proceedings, 2024, v. 45, n. 4, p. 219, doi. 10.2500/aap.2024.45.240018
- By:
- Publication type:
- Article
Dupilumab efficacy in patients with chronic rhinosinusitis with nasal polyps with and without allergic rhinitis.
- Published in:
- Allergy & Asthma Proceedings, 2023, v. 44, n. 4, p. 265, doi. 10.2500/aap.2023.44.230015
- By:
- Publication type:
- Article
262. DUPILUMAB REDUCED EOSINOPHIL COUNTS AND IMPROVED HISTOLOGY GRADE/STAGE SCORES IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: LIBERTY EOE TREET RESULTS.
- Published in:
- Diseases of the Esophagus, 2023, v. 36, p. 1, doi. 10.1093/dote/doad052.103
- By:
- Publication type:
- Article
Rapid and Sustained Improvement in Sense of Smell With Dupilumab in Patients With Severe Chronic Rhinosinusitis With Nasal Polyps and 0, 1, 2, or ≥3 Prior Sinonasal Surgeries (SNS): Pooled Results From the SINUS-24 and SINUS-52 Phase 3 Studies.
- Published in:
- Rhinology Supplement, 2021, v. 61, p. 587
- By:
- Publication type:
- Article
The prevalence of type 2 inflammatory signatures in patients with chronic rhinosinusitis with nasal polyps from two phase 3 clinical trials, SINUS-24 and SINUS-52.
- Published in:
- Rhinology Supplement, 2021, v. 61, p. 351
- By:
- Publication type:
- Article
The relationship of sinus opacification, olfaction and dupilumab efficacy in patients with CRSwNP.
- Published in:
- Rhinology, 2023, v. 61, n. 6, p. 531, doi. 10.4193/Rhin22.220
- By:
- Publication type:
- Article
Impact of Dupilumab on Sinonasal Symptoms and Outcomes in Severe Chronic Rhinosinusitis With Nasal Polyps.
- Published in:
- Otolaryngology-Head & Neck Surgery, 2024, v. 170, n. 4, p. 1173, doi. 10.1002/ohn.627
- By:
- Publication type:
- Article
Dupilumab Efficacy in Patients with Type 2 Asthma with and without Elevated Blood Neutrophils.
- Published in:
- Journal of Immunology Research, 2023, p. 1, doi. 10.1155/2023/9943584
- By:
- Publication type:
- Article
Dupilumab improves outcomes in patients with chronic rhinosinusitis with nasal polyps irrespective of gender: results from the SINUS‐52 trial.
- Published in:
- Clinical & Translational Immunology, 2024, v. 13, n. 6, p. 1, doi. 10.1002/cti2.1511
- By:
- Publication type:
- Article
Dupilumab provides early and durable improvement of symptoms in patients with chronic rhinosinusitis with nasal polyps.
- Published in:
- Clinical & Translational Immunology, 2023, v. 12, n. 1, p. 1, doi. 10.1002/cti2.1433
- By:
- Publication type:
- Article
Efficacy of dupilumab in patients with uncontrolled, moderate‐to‐severe asthma with fungal sensitization.
- Published in:
- Clinical & Experimental Allergy, 2023, v. 53, n. 10, p. 1020, doi. 10.1111/cea.14389
- By:
- Publication type:
- Article
Improvement in patient‐reported "taste" and association with smell in dupilumab‐treated patients with severe chronic rhinosinusitis with nasal polyps from the SINUS‐24 and SINUS‐52 trials.
- Published in:
- Clinical & Experimental Allergy, 2022, v. 52, n. 9, p. 1105, doi. 10.1111/cea.14194
- By:
- Publication type:
- Article
Responder analysis to demonstrate the effect of targeting type 2 inflammatory mechanisms with dupilumab across objective and patient‐reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps in the SINUS‐24 and SINUS‐52 studies
- Published in:
- Clinical & Experimental Allergy, 2022, v. 52, n. 2, p. 244, doi. 10.1111/cea.14051
- By:
- Publication type:
- Article
Dupilumab efficacy across serum IgE and blood eosinophil levels in chronic rhinosinusitis with nasal polyposis.
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2858, doi. 10.1111/all.16189
- By:
- Publication type:
- Article
Dupilumab sustains efficacy in patients with moderate‐to‐severe type 2 asthma regardless of inhaled corticosteroids dose.
- Published in:
- Allergy, 2023, v. 78, n. 11, p. 2921, doi. 10.1111/all.15792
- By:
- Publication type:
- Article
Dupilumab improves long‐term outcomes in patients with uncontrolled, moderate‐to‐severe GINA‐based type 2 asthma, irrespective of allergic status.
- Published in:
- Allergy, 2023, v. 78, n. 8, p. 2148, doi. 10.1111/all.15747
- By:
- Publication type:
- Article
Assessment of dupilumab in children with moderate‐to‐severe type 2 asthma with or without evidence of allergic asthma.
- Published in:
- Allergy, 2023, v. 78, n. 8, p. 2157, doi. 10.1111/all.15743
- By:
- Publication type:
- Article
Dupilumab reduced impact of severe exacerbations on lung function in patients with moderate‐to‐severe type 2 asthma.
- Published in:
- Allergy, 2023, v. 78, n. 1, p. 233, doi. 10.1111/all.15456
- By:
- Publication type:
- Article
Long-term efficacy of dupilumab in severe asthma by baseline oral corticosteroid dose.
- Published in:
- ERJ Open Research, 2023, v. 9, n. 6, p. 1, doi. 10.1183/23120541.00056-2023
- By:
- Publication type:
- Article
The interleukin-4/interleukin-13 pathway in type 2 inflammation in chronic rhinosinusitis with nasal polyps.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1356298
- By:
- Publication type:
- Article
Dupilumab-Treated Patients with Asthma in the Real World: The RAPID Global Registry.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 3, p. 1292, doi. 10.1007/s12325-022-02399-5
- By:
- Publication type:
- Article
Efficacy and Safety of Dupilumab Versus Omalizumab in Chronic Rhinosinusitis With Nasal Polyps and Asthma: EVEREST Trial Design.
- Published in:
- American Journal of Rhinology & Allergy, 2022, v. 36, n. 6, p. 788, doi. 10.1177/19458924221112211
- By:
- Publication type:
- Article